Cost and utility analysis of a store-and-forward teledermatology referral system: A randomized clinical trial

JAMA Dermatology

Volumn 151, Issue 12, 2015, Pages 1323-1329

  Datta, Santanu K ^a,b   Warshaw, Erin M ^c,d   Edison, Karen E ^e   Kapur, Kush ^f   Thottapurathu, Lizy ^g   Moritz, Thomas E ^g   Reda, Domenic J ^g   Whited, John D ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Minneapolis Veterans Affairs Health Care System   (United States)

^e University of Missouri   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CARE COST; HUMAN; MALE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STORE AND FORWARD TELEDERMATOLOGY; TELEDERMATOLOGY; TIME TRADE OFF METHOD;

EID: 84949665843     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.2362     Document Type: Article

References (16)

1. GoldMR, Siegel JE, Russell LB,Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
2. Davidoff AJ, Powe NR. The role of perspective in defining economic measures for the evaluation of medical technology. Int J Technol Assess Health Care. 1996;12(1):9-21.
3. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986; 5(1):1-30.
4. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7(2):118-133.
5. Chen SC, Bayoumi AM, Soon SL, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9(2):160-168.
6. Whited JD,Warshaw EM, Edison KE, et al. Effect of store and forward teledermatology on quality of life: a randomized controlled trial. JAMA Dermatol. 2013;149(5):584-591.
7. Whited JD,Warshaw EM, Kapur K, et al. Clinical course outcomes for store and forward teledermatology versus conventional consultation: a randomized trial. J Telemed Telecare. 2013;19(4): 197-204.
8. Centers for Medicare & Medicaid Services. License for Use of Current Procedural Terminology, Fourth Edition. http://www.cms.gov/apps /physician-fee-schedule/license-agreement.aspx. Accessed July 17, 2015.
9. Internal Revenue Service. IRS increases mileage rate to 55.5 cents per mile. http://www.irs.gov/uac /IRS-Increases-Mileage-Rate-to-55.5-Cents-per -Mile. Accessed September 26, 2014.
10. United States Bureau of Labor Statistics. Comparison of all employee average hourly earnings, seasonally adjusted, before and after the March 2013 benchmark. http://www.bls.gov/web /empsit/compaehes.txt. Accessed October 10, 2014.
11. Barker N. A practical introduction to the bootstrap using the SAS system.Wallingford, England: Oxford Pharmaceutical Sciences. Paper PK02. http://www.lexjansen.com/phuse/2005/pk /pk02.pdf. Accessed July 17, 2015.
12. Whited JD, Datta S, Hall RP, et al. An economic analysis of a store and forward teledermatology consult system. Telemed J E Health. 2003;9(4):351-360.
13. Pak HS, Datta SK, Triplett CA, Lindquist JH, Grambow SC, Whited JD. Costminimization analysis of a store-and-forward teledermatology consult system. Telemed J E Health. 2009;15(2): 160-165.
14. Leeyaphan C,Wanitphakdeedecha R, ManuskiattiW, Kulthanan K. Measuring melasma patients' quality of life using willingness to pay and time trade-offmethods in Thai population. BMC Dermatol. 2011;11:16. doi:10.1186/1471-5945-11-16.
15. Chen CL, Kuppermann M, Caughey AB, Zane LT. A community-based study of acne-related health preferences in adolescents. Arch Dermatol. 2008; 144(8):988-994.
16. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, LindbergM. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol. 1999;141(6):1067-1075.